IV drips deliver hydration and essential nutrients directly into your bloodstream for better absorption and faster results
The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary
BPC-157 (Body Protection Compound-157) is an artificial peptide composed of 15 amino acids, based on a natural protein that is present in the stomach, and that is studied due to its healing and regenerative effects
Peer-reviewed studies on BPC-157 Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH (2011)
Yes, the Wegovy pill has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, meaning it has been deemed safe for use